Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22.
acute respiratory infection
case-control study
influenza
influenza vaccine
repeated vaccination
vaccine effectiveness
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
6
7
2022
Statut:
ppublish
Résumé
Compared with individuals unvaccinated in the current and three previous influenza seasons, in 2021/22, influenza vaccine effectiveness at primary care level was 37% (95% CI: 16 to 52) for current season vaccination, regardless of previous doses, and 35% (95% CI: -3 to 45) for only previous seasons vaccination. Against influenza A(H3N2), estimates were 39% (95% CI: 16 to 55) and 24% (95% CI: -8 to 47) suggesting moderate effectiveness of current season vaccination and possible remaining effect of prior vaccinations.
Identifiants
pubmed: 35775428
doi: 10.2807/1560-7917.ES.2022.27.26.2200488
pmc: PMC9248265
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Euro Surveill. 2022 Apr;27(15):
pubmed: 35426361
Vaccine. 2010 Oct 28;28(46):7381-8
pubmed: 20851086
Clin Infect Dis. 2014 Nov 15;59(10):1375-85
pubmed: 25270645
BMC Med. 2019 Jan 10;17(1):9
pubmed: 30626399
Clin Infect Dis. 2022 Mar 24;:
pubmed: 35325923
MMWR Morb Mortal Wkly Rep. 2022 Mar 11;71(10):365-370
pubmed: 35271561
Euro Surveill. 2012 Apr 26;17(17):
pubmed: 22551499
Euro Surveill. 2022 Apr;27(15):
pubmed: 35426364
Euro Surveill. 2021 Aug;26(32):
pubmed: 34387185